Optimization of a peptide-based protocol employing IL-7 for in vitro restimulation of human cytotoxic T lymphocyte precursors

Journal of Immunological Methods

Volumn 210, Issue 1, 1997, Pages 65-77

  Lalvani, Ajit ^a   Dong, Tao ^a   Ogg, Graham ^a   Pathan, Ansar A ^a   Newell, Heidi ^a   Hill, Adrian V S ^a   McMichael, Andrew J ^a   Rowland Jones, Sarah ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

CTL activity; Human cytotoxic; IL 7; T lymphocyte precursor

Indexed keywords

CHROMIUM; HLA A2 ANTIGEN; INTERLEUKIN 7; PEPTIDE; VIRUS ANTIGEN;

ANTIGEN PRESENTATION; ARTICLE; CD8+ T LYMPHOCYTE; CELL SEPARATION; CRYOPRESERVATION; CULTURE TECHNIQUE; CYTOLOGY; CYTOTOXIC T LYMPHOCYTE; DOSE RESPONSE; HEMATOPOIETIC STEM CELL; HISTOCOMPATIBILITY TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METHODOLOGY; MONONUCLEAR CELL; SYNTHESIS; TIME;

ANTIGEN PRESENTATION; ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; CELL CULTURE TECHNIQUES; CELL SEPARATION; CHROMIUM; CRYOPRESERVATION; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HEMATOPOIETIC STEM CELLS; HISTOCOMPATIBILITY TESTING; HIV-1; HLA-A2 ANTIGEN; HUMANS; IMMUNOLOGIC MEMORY; INTERLEUKIN-7; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; PEPTIDES; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS;

EID: 0031573683     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(97)00177-4     Document Type: Article

References (26)

1. Aidoo, M., Lalvani, A., Allsopp, C.E.M., Plebanski, M., Meisner, S.J., Browning, M., Morris-Jones, S., Gotch, F., Fidock, D.A., Takiguchi, M., Robson, K.J.H., Greenwood, B.M., Druilhe, P., Whittle, H.C., Hill, A.V.S., 1995. Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria. Lancet 345, 1003.
2. Aidoo, M., Lalvani, A., Whittle, H.C., Hill, A.V.S., Robson, K.J.H., 1997. Recombinant vaccinia viruses for the characterization of Plasmodium falciparum-specific cytotoxic T lymphocytes: Recognition of processed antigen despite limited restimulation efficacy. Int. Immunol. 9, 731.
3. Altman, J.D., Moss, P.A.H., Goulder, P.J.R., Barouch, D.H., McHeyzer-Williams, M.G., Bell, J.I., McMichael, A.J., Davis, M.M., 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274, 94.
4. Borysiewicz, L.K., Fiander, A., Nimako, M., Man, S., Wilkinson, G.W.G., Westmoreland, D., Evans, A.S., Adams, M., Stacey, S.N., Boursnell, M.E.G., Rutherford, E., Hickling, J.K., Inglis, S.C., 1996. A recombinant vaccinia virus encoding human papilloma virus types16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer. Lancet 347, 1523.
5. Bowness, P., Moss, P.A.H., Rowland-Jones, S.L., Bell, J.I., McMichael, A.J., 1993. Conservation of T cell receptor usage by HLA-B27-restricted influenza-specific CTL suggests a general pattern for antigen-specific MHC class I-restricted responses. Eur. J. Immunol. 23, 1417.
6. Carini, C., Essex, M., 1994. 11-2 independent IL-7 activity enhances cytotoxic immune response of HIV-1 infectedc individuals. Aids Res. Hum. Retr. 10, 121.
7. Celis, E., Tsai, V., Crimi, C., deMars, R., Wentworth, P.A., Chesnut, R.W., Grey, H.M., sette, A., Serra, H.M., 1994. Induction of anti-tumor CTL in normal humans using primary cultures and synthetic peptide epitopes. Proc. Natl. Acad. Sci. USA 91, 2105.
8. Dadmarz, R., Bockstoce, D.C., Golub, S.H., 1994. IL-7 selectively enhances natural kill cytotoxicity mediated by the CD56-bright natural killer population. Lymphokine Cytokine Res. 13, 349.
9. Dong, T., Boyd, D., Rosenberg, W., Alp, N., Takiguchi, M., McMichael, A.J., Rowland-Jones, S., 1996. Increased affinity for HLA-B35 of an influenza A epitope modified at an anchor residue results in an antagonistic peptide. Eur. J. Immunol. 26, 335.
10. Garboczi, D.N., Hung, D.T., Wiley, D.C., 1992. HLA-A2-peptide complexes: Refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenie peptides. Proc. Natl. Acad. Sci. USA 89, 3429.
11. Hickman, C.J., Crim, J.A., Mostowski, H.S., Siegel, J.P., 1990. Regulation of human cytotoxic T lymphocyte development by IL-7. J. Immunol. 145, 2415.
12. Hill, A.V.S., Elvin, J., Willis, A., Aidoo, M., Allsopp, C.E.M., Gotch, F.M., Gao, X.M., Takiguchi, M., Greenwood, B.M., Townsend, A.R.M., McMichael, A.J., Whittle, H.C., 1992. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360, 434.
13. Kos, F.J., Muellbacher, A., 1993. IL-2 independent activity of IL-7 in the generation of secondary antigen-specific cytotoxic T cell responses in vitro. J. Immunol. 150, 387.
14. Ferrari, G., King, K., Rathbun, K., Place, C.A., Packard, M.V., Bartlett, J.A., Bolognesi, D.P., Weinhold, K.J., 1995. IL-7 enhancement of antigen-driven activation/expansion of HIV-1-specific cytotoxic T lymphocyte precursors (CTLp). Clin. Exp. Immunol. 101, 239.
15. Gotch, F.M., Rothbard, J., Howland, K., Townsend, A., McMichael, A.J., 1987. Cytotoxic T lymphocytes recognise a fragment of influenza virus matrix protein in association with HLA-A2. Nature 326, 881.
16. Krausa, P., Bodmer, J.G., Browning, M.J., 1993. Defining the common subtypes of HLA A9, A10, A28 and A19 by use of ARMS/PCR. Tissue Antigens 42, 91-99.
17. Lalvani, A., Brookes, R., Wilkinson, R., Malin, A.S., Pathan, A.A., Dockrell, H., Andersen, P., Pasvol, G., Hill, A.V.S., 1997. Human cytolytic and interferon-gamma secreting CD8 + T cells specific for Mycobacterium tuberculosis. J. Immunol. Methods, submitted.
18. Lee, S.P., Morgan, S., Skinner, J., Thomas, W.A., Rowland-Jones, S.L., Khanna, R., Whittle, H.C., Rickinson, A.B., 1995. EBV isolates with the major HLA B35.01-restricted CTL epitope are prevalent in a highly B35.01-positive African population. Eur. J. Immunol. 25, 102.
19. Martinon, F., Gomard, E., Hannoun, C., Levy, J.-P., 1990. In vitro human cytotoxic T cell responses against influenza A virus can be induced and selected by synthetic peptides. Eur. J. Immunol. 20, 2171.
20. Morrison, J., Elvin, J., Latron, F., Gotch, F., Moots, R., Strominger, J.L., McMichael, A.J., 1992. Identification of the nonamer peptide from influenza-A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytes. Eur. J. Immunol. 22, 903-907.
21. Nixon, D., Townsend, A.R.M., Elvin, J., Rizza, C., Gallway, J., McMichael, A.J., 1988. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature 336, 484.
22. Plebanski, M., Allsopp, C.E.M., Aidoo, M., Reyburn, H., Hill, A.V.S., 1995. Induction of peptide-specific primary CTL responses from human peripheral blood. Eur. J. Immunol. 25, 1783.
23. Plebanski, M., Aidoo, M., Whittle, H.C., Hill, A.V.S., 1997. Precursor frequency analysis of cytotoxic T lymphocytes to pre-erythrocytic antigens of Plasmodium falciparum in West Africa. J. Immunol. 158, 2849.
24. Rowland-Jones, S., Sutton, J., Ariyoshi, K., Dong, T., Gotch, F., McAdam, S., Whitby, D., Sabally, S., Galimore, A., Corrah, T., Takiguchi, M., Schultz, T., McMichael, A.J., Whittle, H., 1995. HIV-specific CTL in HIV-exposed but uninfected Gambian women. Nat. Med. 1, 59.
25. Schatz, P.J., 1993. Use of peptide libraries to map the substrate specificity of a peptide-modifying enzyme: A 13 residue consensus peptide specifies biotinylation in Escherichia coli. Biotechnology 11, 1138.
26. Sutton, J., Rowland-Jones, S., Rosenberg, W., Nixon, D., Gotch, F., Gao, X.M., Murray, N., Spoonas, A., Driscoll, P., 1993. A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA-B8 revealed by analysis of epitopes and eluted peptides. Eur. J. Immunol. 23, 447.